Published in G Ital Med Lav Ergon on February 24, 2004
Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer (2009) 1.99
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax (2007) 1.54
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot? Oncotarget (2017) 0.75
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results. J Thromb Haemost (2012) 2.04
Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med (2007) 1.60
Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost (2001) 1.55
Effect of nitrous oxide on desflurane MACBAR at two target-controlled concentrations of remifentanil. Minerva Anestesiol (2008) 1.48
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics. Intern Emerg Med (2007) 1.41
Exposure-effect and exposure-response relationships between occupational exposure to styrene and neuropsychological functions. Am J Ind Med (1984) 1.39
The role of cysteine and homocysteine in venous and arterial thrombotic disease. Am J Clin Pathol (2001) 1.38
Mortality experience among chromeplating workers. Initial findings. Scand J Work Environ Health (1983) 1.31
Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am J Respir Crit Care Med (2001) 1.26
Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health (1995) 1.23
Impact of recent legislative bills regarding clinical research on Italian ethics committee activity. J Med Ethics (2008) 1.18
Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med (1993) 1.18
Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int (1992) 1.17
Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med (1993) 1.16
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost (2012) 1.11
Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med (1993) 1.10
Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy. Eur J Clin Microbiol Infect Dis (2005) 1.10
A cross-sectional survey of kidney function in refinery employees. Am J Ind Med (1987) 1.09
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J (2007) 1.08
Surgical treatment of primary and metastatic sternal tumours. J Cardiovasc Surg (Torino) (2001) 1.07
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost (2010) 1.06
Lung epithelial damage at low concentrations of ambient ozone. Lancet (1999) 1.06
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA). Thromb Haemost (2011) 1.06
A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology (1998) 1.06
n-Hexane metabolism in occupationally exposed workers. Br J Ind Med (1984) 1.05
Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study. Occup Environ Med (2007) 1.05
Nephrotoxicity of chromium. Remarks on an experimental and epidemiological investigation. Contrib Nephrol (1978) 1.05
n-Hexane-induced changes in nerve conduction velocities and somatosensory evoked potentials. Int Arch Occup Environ Health (1982) 1.04
Neuroendocrine effects of styrene on occupationally exposed workers. Scand J Work Environ Health (1984) 1.04
Evaluation of oxidative damage and inhibition of DNA repair in an in vitro study of nickel exposure. Toxicol In Vitro (2003) 1.01
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J (2004) 1.01
Tracheobronchial laceration after double-lumen intubation for thoracic procedures. Ann Thorac Surg (1998) 1.00
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
Adverse effects of chronic low level lead exposure on kidney function--a risk group study in children. Nephrol Dial Transplant (1998) 0.99
Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient. J Antimicrob Chemother (2004) 0.98
Urinary N-acetyl-beta-D-glucosaminidase activity in workers exposed to inorganic lead. Occup Environ Med (1994) 0.98
Determination of naphthalene metabolites in human urine by liquid chromatography-mass spectrometry with electrospray ionization. J Chromatogr A (1999) 0.97
Peripheral biomarkers and exposure to manganese. Neurotoxicology (1999) 0.96
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer (2013) 0.96
Acute renal failure after isolated CABG surgery: six years of experience. Minerva Anestesiol (2007) 0.95
[Italian D.Law 81/2008: confirmation and news in the subject of work-related stress]. G Ital Med Lav Ergon (2009) 0.95
Styrene metabolism and striatal dopamine depletion in rabbits. Arch Toxicol Suppl (1985) 0.93
Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals. Occup Environ Med (2003) 0.93
Effects of some monocyclic aromatic solvents and their metabolites on brain dopamine in rabbits. J Appl Toxicol (1986) 0.93
Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet (1999) 0.92
The role of chromium accumulation in the relationship between airborne and urinary chromium in welders. Int Arch Occup Environ Health (1979) 0.92
Urinary excretion of brush-border antigen revealed by monoclonal antibody: early indicator of toxic nephropathy. Lancet (1985) 0.91
Occupational risk factors for renal cell cancer. An Italian case-control study. Med Lav (2002) 0.91
Impaired dopaminergic modulation of pituitary secretion in workers occupationally exposed to styrene: further evidence from PRL response to TRH stimulation. J Occup Med (1987) 0.90
Neurophysiological changes in workers exposed to organic solvents in a shoe factory. Scand J Work Environ Health (1982) 0.90
Serum clara cell protein: a sensitive biomarker of increased lung epithelium permeability caused by ambient ozone. Environ Health Perspect (2000) 0.89
Premium rebates and the quiet consensus on market reform for Medicare. Health Care Financ Rev (2001) 0.89
Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal. J Thromb Haemost (2008) 0.88
Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Eur J Vasc Endovasc Surg (2010) 0.88
Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol (1996) 0.87
CT-guided transthoracic needle biopsy in the diagnosis of chest tumours. J Cardiovasc Surg (Torino) (1997) 0.87
Early indicators of renal damage in workers exposed to organic solvents. Int Arch Occup Environ Health (1983) 0.87
Selected toxicological aspects of chromium(VI) compounds. Sci Total Environ (1988) 0.86
Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol (1994) 0.86
Neurobehavioral and neuroendocrine effects of occupational exposure to perchloroethylene. Neurotoxicology (1992) 0.85
The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ Res (1997) 0.85
Regional alterations of brain catecholamines by styrene exposure in rabbits. Arch Toxicol (1984) 0.85
Spontaneous intercostal pulmonary hernia. J Cardiovasc Surg (Torino) (2000) 0.85
Styrene 7,8-oxide induces mitochondrial damage and oxidative stress in neurons. Toxicology (2004) 0.84
The outcome of patients requiring emergency conversion from off-pump to on-pump coronary artery bypass grafting. Eur J Anaesthesiol (2006) 0.84
Leiomyosarcoma of the superior vena cava. Ann Thorac Surg (1996) 0.84
Surgical outcome of combined pulmonary and atrial resection for lung cancer. Thorac Cardiovasc Surg (2004) 0.84
Organic solvents and chronic glomerulonephritis: a cross-sectional study with negative findings for aliphatic and alicyclic C5-C7 hydrocarbons. J Appl Toxicol (1981) 0.84
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin Chim Acta (1995) 0.84
Peripheral markers of catecholaminergic dysfunction and symptoms of neurotoxicity among styrene-exposed workers. Int Arch Occup Environ Health (1997) 0.84
Biological variables in non-small cell lung cancer: comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sections. Lung Cancer (2000) 0.83
Vascular effects of occupational exposure to low-dose ionizing radiation. Am J Ind Med (1996) 0.82
Progression of chronic adriamycin nephropathy in leukopenic rats. Nephron (1993) 0.82
Hydrophobic interaction of alcian blue with soluble and erythrocyte membrane proteins. J Chromatogr (1988) 0.82
Solid-phase microextraction gas chromatographic-mass spectrometric method for the determination of inhalation anesthetics in urine. J Chromatogr B Biomed Sci Appl (1999) 0.82
[Urinary excretion of 4-vinyl phenol after experimental and occupational exposure to styrene]. G Ital Med Lav Ergon (2004) 0.82
Enzyme-linked immunosorbent assay of retinol-binding protein in serum and urine. Clin Chem (1984) 0.82
Inter- and intra-individual sources of variation in levels of urinary styrene metabolites. Int Arch Occup Environ Health (2001) 0.82
Assessing variability and comparing short-term biomarkers of styrene exposure using a repeated measurements approach. Toxicol Lett (2009) 0.81
Experimental model of lead nephropathy. II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA). Environ Res (1992) 0.81
Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line. Cancer Lett (2006) 0.81
Peripheral markers of neurochemical effects among styrene-exposed workers. Neurotoxicology (1997) 0.81
Late spontaneous chylopericardium following complex cardiac surgery. J Cardiovasc Surg (Torino) (1995) 0.81
Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chem Res Toxicol (2001) 0.81
Effects derived from long-term low-level chromium exposure in ferro-alloy metallurgy. Study of absorption and renal function in workers. Sci Total Environ (1988) 0.81
Methylmercury at low doses modulates the toxicity of PCB153 on PC12 neuronal cell line in asynchronous combination experiments. Food Chem Toxicol (2007) 0.81
Neuropsychological deficits in arterial hypertension. Acta Neurol Scand (1986) 0.81
Quantitative characterization of the growth of the fetal kidney. J Clin Ultrasound (1983) 0.81
The modified "hemi-clamshell" approach for tumors of the cervicothoracic junction. Ann Thorac Surg (2000) 0.80
Styrene-induced changes in amacrine retinal cells: an experimental study in the rat. Neurotoxicology (2000) 0.80